Workflow
Quantum BioPharma Announces Intention to Declare Special Dividend of Contingent Value Rights (CVRs) Linked to Future Litigation Settlement Proceeds
Globenewswire· 2025-06-13 19:00
TORONTO, June 13, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, is pleased to announce its intention to declare a special dividend consisting of Contingent Value Rights (the “CVRs”) to be issued on a 1:1 basis to holders of the Company’s Class B Subordinate Voting Shares. Each CVR will entitle the holder to receive a pro ra ...
NexGold Infill Drilling Intersects 25.79 g/t Gold Over 4.5 Metres and 18.09 g/t Gold over 3.0 Metres at the Goldboro Gold Project
Globenewswire· 2025-06-13 19:00
TORONTO, June 13, 2025 (GLOBE NEWSWIRE) -- NexGold Mining Corp. (TSXV: NEXG; OTCQX: NXGCF) (“NexGold” or the “Company”) is pleased to provide an update on its ongoing 25,000-metre diamond drill program initially announced on January 22, 2025 at the Company’s Goldboro Project in Nova Scotia (“Goldboro”). The drill program is primarily designed to infill specific areas of the open pit Mineral Resource identified to improve geological and grade continuity and potentially upgrade certain areas of Inferred and I ...
Biomea Fusion Presents Updated Preliminary Clinical Data for Covalent FLT3 Inhibitor BMF-500 in Relapsed or Refractory Acute Leukemia at EHA 2025
Globenewswire· 2025-06-13 18:45
New clinical results show sustained CRi, deep bone marrow responses, and encouraging survival in FLT3-mutant AML patients, including those previously treated with gilteritinibREDWOOD CITY, Calif., June 13, 2025 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea” or the “Company”) (Nasdaq: BMEA), a clinical-stage diabetes and obesity medicines company, today announced updated preliminary clinical data from the ongoing Phase I COVALENT-103 trial of BMF-500 in adults with relapsed or refractory (“R/R”) acute leu ...
2025 Heyball Parasport World Championship Opens in Brisbane, Championing Olympic Inclusion
Globenewswire· 2025-06-13 18:31
文章核心观点 2025年Heyball残疾人体育世界锦标赛在澳大利亚布里斯班开幕,这是Heyball运动40年历史上首个国际顶级残疾人赛事,对Heyball发展和全球残疾人体育意义重大,也为其进入奥运会填补关键空白 [1][3][5] 赛事基本信息 - 2025年Heyball残疾人体育世界锦标赛于6月13日在布里斯班板球场开幕,主题曲为“Nothing is Gonna Hold You Back” [1] - 赛事由JOY和Liber Win联合呈现,有来自17个国家和地区的64名优秀残疾运动员参赛 [1] - 设有女子(轮椅/站立混合)、男子轮椅和男子站立三个组别,奖金池为6万美元 [3] 出席人员 - 世界台球协会(WPA)主席Ishaun Singh、秘书长Barry Jenner、残疾人体育总监Henrik Larsson、体育总监Jorgen Sandman以及JOY创始人Qiao Yuanxu出席开幕式 [4] 赛事意义 - 是Heyball运动发展的重要里程碑,为全球残疾人体育注入新动力 [3] - 填补了Heyball进入奥运会途径的关键空白,完善了赛事体系,推动其迈向奥运会 [5] - 体现体育超越局限的力量,展示体育卓越不受身体限制 [5] - 践行JOY“JOY Billiards Uniting The World”愿景和“Heyball to Olympics – No One Left Behind”原则 [5] 赛事安排 - 比赛将通过抖音(TikTok)、Facebook和YouTube进行全球直播 [5]
Hyperscale Data's Subsidiary, Sentinum, Announces Anticipated Annual Bitcoin Mining Run Rate of Approximately $41 Million
Globenewswire· 2025-06-13 18:30
文章核心观点 - 超大规模数据公司旗下子公司Sentinum预计自2025年7月起每年开采约375.24枚比特币,年运营率约4100万美元,公司还计划剥离子公司Ault Capital Group [1][3][6] 公司业务情况 - 超大规模数据公司是多元化控股公司,通过子公司Sentinum运营数据中心,从事数字资产开采、提供托管和主机服务,另一子公司Ault Capital Group是多元化控股公司,收购低估企业和颠覆性技术 [5] 比特币开采计划 - Sentinum预计自2025年7月起每年开采约375.24枚比特币,当前比特币开采年运营率约4100万美元,基于近期比特币价格约10.8万美元 [1] - 该预测基于约9100台密歇根数据中心运营的矿机、6800台蒙大拿OP LLC托管且预计6月底交付安装运营的矿机、3300台蒙大拿数据中心运营的矿机(其中2600台预计6月底运营,700台7月运营) [2] 公司管理层表态 - 公司创始人兼执行主席Milton "Todd" Ault III表示达到该里程碑值得骄傲,预计的比特币开采年运营率凸显公司规模和团队执行能力,期待Sentinum团队下月投入10100台比特币矿机运营 [3] 子公司剥离计划 - 公司预计2025年12月31日左右剥离Ault Capital Group,剥离后公司将专注于数据中心运营以支持高性能计算服务,可能继续开采比特币,剥离前Ault Capital Group及其子公司和战略投资将继续为多行业提供关键产品,还通过持牌贷款子公司开展私人信贷和结构化金融业务 [6] - 2024年12月23日公司向普通股股东和C系列可转换优先股股东发行100万份F系列可交换优先股,剥离将通过F系列可交换优先股自愿交换Ault Capital Group的A类普通股和B类普通股完成,只有同意交出F系列优先股且未撤回的股东才能获得Ault Capital Group股份 [7] 投资者信息 - 投资者可阅读公司在hyperscaledata.com投资者关系板块或www.sec.gov上的公开文件和新闻稿获取更多信息 [4] - 公司投资者联系方式为IR@hyperscaledata.com或1 - 888 - 753 - 2235 [11]
NioBay Announces Election of Directors
Globenewswire· 2025-06-13 18:28
MONTREAL, June 13, 2025 (GLOBE NEWSWIRE) -- NioBay Metals Inc. (“NioBay” or the “Company”) (TSX-V: NBY) (OTCQB: NBYCF) is pleased to announce the results of its annual general meeting (“AGM”) of shareholders held on June 12, 2025. Shareholders holding a total of 49,363,869 common shares of the Company attended the AGM in person or were represented by proxy, representing over 46% of the 107,277,572 common shares issued and outstanding. Jean-Sébastien David, Josianne Beaudry, Laurence Farmer, Raymond Legault, ...
Robex remains on track for first gold at Kiniero in Q4 2025
Globenewswire· 2025-06-13 18:28
Highlights: Construction at Robex’s Kiniero Gold Project, Guinea, remains on schedule and budget with first gold pour on track for Q4 2025.Project remains LTI free (lost time injury).All project engineering and detail design completed.Phase 1 grade control drilling of Mansounia pit continues, with 55,430m drilled and 61,520 samples collected. Mansounia drilling to be completed by end of June, with drilling to commence at the Sabali pit.SMP (Structural, Mechanical & Piping) works commenced, with 115 tonnes e ...
Springview Holdings Ltd Achieves bizSAFE Level 4 Certification, Accelerating Growth and Expanding Market Reach
Globenewswire· 2025-06-13 18:15
Singapore, June 13, 2025 (GLOBE NEWSWIRE) -- Springview Holdings Ltd (Nasdaq: SPHL) (“Springview Holdings”, or the “Company”), a leading designer and builder of residential and commercial properties in Singapore, today announced that its indirect wholly owned Singapore operating subsidiary, Springview Enterprises Pte. Ltd. (“Springview Singapore”) has been officially awarded bizSAFE Level 4 certification by the Workplace Safety and Health Council, effective June 9, 2025. This milestone marks a major leap f ...
Enliven Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
Prnewswire· 2025-06-13 18:10
BOULDER, Colo., June 13, 2025 /PRNewswire/ -- Enliven Therapeutics, Inc. (Enliven or the Company) (Nasdaq: ELVN), a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics, today announced that it has commenced an underwritten public offering of $200 million of shares of its common stock and, in lieu of common stock to investors who so choose, pre-funded warrants to purchase shares of Enliven's common stock. In addition, Enliven intends to grant the u ...
Bilibili Inc. Announces Completion of the Repurchase Right of Its 1.25% Convertible Senior Notes due 2027
Globenewswire· 2025-06-13 18:00
SHANGHAI, June 13, 2025 (GLOBE NEWSWIRE) -- Bilibili Inc. (“Bilibili” or the “Company”) (Nasdaq: BILI and HKEX: 9626), an iconic brand and a leading video community for young generations in China, today announced that it has completed its previously announced repurchase right relating to its 1.25% Convertible Senior Notes due 2027 (CUSIP No. 090040AD8) (the “Notes”). The repurchase right expired at 5:00 p.m., New York City time, on Thursday, June 12, 2025. Based on information from Deutsche Bank Trust Compa ...